Prosecution Insights
Last updated: May 29, 2026

Examiner: PARISI, JESSICA DANIELLE

Tech Center 1600 • Art Units: 1637 1675 1684

This examiner grants 80% of resolved cases

Performance Statistics

79.8%
Allow Rate
+19.8% vs TC avg
133
Total Applications
+28.0%
Interview Lift
1277
Avg Prosecution Days
Based on 89 resolved cases, 2023–2026

Rejection Statute Breakdown

1.8%
§101 Eligibility
15.3%
§102 Novelty
61.4%
§103 Obviousness
3.9%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18315316 FLOW CYTOMETRY ATTENUATED REPORTER EXPRESSION (FLARE) MULTIPLE REPORTER SYSTEM AND METHODS OF USE THEREOF Non-Final OA Genzyme Corporation
19082018 ANALYSIS OF NUCLEIC ACID SEQUENCES Non-Final OA 10X GENOMICS, INC.
17098912 MAGNETIC CAPTURE BEAD MEDIATED MOLECULAR BARCODING OF NUCLEIC ACID TARGETS IN SINGLE PARTICLES AND COMPOSITIONS FOR USE IN THE SAME Non-Final OA Becton, Dickinson and Company
18139689 METHODS AND COMPOSITIONS FOR CLUSTER GENERATION BY BRIDGE AMPLIFICATION Non-Final OA ILLUMINA CAMBRIDGE LIMITED
18153946 SEQUENCING FROM MULTIPLE PRIMERS TO INCREASE DATA RATE AND DENSITY Non-Final OA Illumina Cambridge Limited
17922340 SEQUENCING METHOD, ANALYSIS METHOD THEREFOR AND ANALYSIS SYSTEM THEREOF, COMPUTER-READABLE STORAGE MEDIUM, AND ELECTRONIC DEVICE Non-Final OA GeneMind Biosciences Co., Ltd.
18061333 METHODS AND SYSTEMS FOR DROPLET MANIPULATION Non-Final OA Volta Labs, Inc.
17787900 METHOD FOR IDENTIFYING REGULATORY ELEMENTS CONFORMATIONALLY Non-Final OA ASKBIO INC.
17773333 A METHOD TO PREPARE PERSONALIZED TARGET-IRRELEVANT GUIDE RNA POOL FOR CRISPR Non-Final OA Siemens Healthcare Diagnostics, Inc.
17996196 A METHOD FOR DETECTION OF WHOLE TRANSCRIPTOME IN SINGLE CELLS Non-Final OA SINGLERON (NANJING) BIOTECHNOLOGIES, LTD.
18249511 METHOD FOR NUCLEIC ACID DETECTION BY OLIGO HYBRIDIZATION AND PCR-BASED AMPLIFICATION Non-Final OA MAX-DELBRÜCK-CENTRUM FÜR MOLEKULARE MEDIZIN IN DER HELMHOLTZ-GEMEINSCHAFT
17920694 SINGLE STEP SAMPLE PREPARATION FOR NEXT GENERATION SEQUENCING Non-Final OA Medicover GmbH
18009149 THREE-DEGREE-OF-FREEDOM LIBRARY PREPARATION CASSETTE AND METHOD USING THE SAME Non-Final OA 3D BIOMEDICINE SCIENCE & TECHNOLOGY CO., LIMITED
17639743 METHOD OF AMPLIFYING MRNAS AND FOR PREPARING FULL LENGTH MRNA LIBRARIES Final Rejection BASECLICK GMBH
17786012 A LIBRARY OF PREFABRICATED MICROPARTICLES AND PRECURSORS THEREOF Non-Final OA BLINK AG
17292046 3D HUMAN CANCER MODEL-BASED COMBINATORIAL DRUG DEVELOPMENT METHOD Final Rejection PreComb Therapeutics AG
17761696 COMPOSITIONS AND METHODS FOR TEMPLATE-FREE DOUBLE STRANDED GEOMETRIC ENZYMATIC NUCLEIC ACID SYNTHESIS Final Rejection Derek STEMPLE
17685881 METHODS OF ANTIBODY PANNING AGAINST TARGET PROTEINS Final Rejection ALEGRE USA LLC
17681060 METHODS AND SYSTEMS FOR RNA-SEQ PROFILING Non-Final OA Honeycomb Biotechnologies, Inc.
17627678 Internal Standard Gene Final Rejection Public University Corporation Fukushima Medical University
17310807 METHODS OF USING MICROFLUIDIC POSITIONAL ENCODING DEVICES Non-Final OA ELEGEN CORPORATION

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month